Saltzman Edward C has filed 4 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 31250 shares of Nurix Therapeutics, Inc. ($NRIX) on May 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Nurix Therapeutics, Inc. | $NRIX | Saltzman Edward C | Director | A | Director Stock Option (right to buy) | 31250 | $0.00 | 31,250.0000 | 102,843,012 | 9999.99% | 0.03% |
| May 19, 2025 | Nurix Therapeutics, Inc. | $NRIX | Saltzman Edward C | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 75,886,817 | 9999.99% | 0.03% |
| May 20, 2024 | Nurix Therapeutics, Inc. | $NRIX | Saltzman Edward C | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 54,337,901 | 9999.99% | 0.05% |
| May 4, 2023 | Nurix Therapeutics, Inc. | $NRIX | Saltzman Edward C | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 48,607,990 | 9999.99% | 0.05% |